BioWorld

June 1, 2004

Avastin, Erbitux Pace Up In Colorectal Market Race

Avigen Stops Coagulin-B Phase I, Plans Drug's Future With Bayer

Expanded Access For Genasense Stopped; Partners Behind Drug

Holiday notice

BioWorld Today's offices are closed Monday, May 31, in observance of Memorial Day. No issue will published that day. Read More

Indevus' Sanctura Gets FDA Nod For Overactive Bladder

Breathing a sigh of satisfaction after years of hard work, officials at Indevus Pharmaceuticals Inc. reached a long-awaited milestone on Friday with the FDA approval of Sanctura. (BioWorld Today) Read More

More Of The Same: Alnylam Gets IPO Done, Below Range

Today's news in brief

BioWorld

BioWorld briefs for April 23, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for April 21, 2026

Psychedelic space expanding on Trump’s EO

BioWorld

Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...

At AACR: Epigenetic fingerprints in metastases track tumor origin

BioWorld

When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...

In the clinic for April 21, 2026

BioWorld

Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...